Mehran Moghaddam

Company: OROX BioSciences Inc.

Job title: Chief Executive Officer

Seminars:

Inhalable Bifunctional sEH/COX-2 Inhibitors for Treatment of Asthma 1:30 pm

Developing inhalable bifunctional sEH/COX-2 small molecule inhibitors with novel mechanisms of action to treat Asthma Asthma affects over 300 million people worldwide and up to 55% of these patients experience recurrent episodes of bronchospasm despite long-acting beta-agonists plus high-dose inhaled or oral corticosteroids Chronic use of corticosteroids can lead to immune suppression, CVD risk, glaucoma,…Read more

day: Conference Day 2